KR850001163A - 머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법 - Google Patents

머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법 Download PDF

Info

Publication number
KR850001163A
KR850001163A KR1019840000560A KR840000560A KR850001163A KR 850001163 A KR850001163 A KR 850001163A KR 1019840000560 A KR1019840000560 A KR 1019840000560A KR 840000560 A KR840000560 A KR 840000560A KR 850001163 A KR850001163 A KR 850001163A
Authority
KR
South Korea
Prior art keywords
acid
formula
alkaline
group
product
Prior art date
Application number
KR1019840000560A
Other languages
English (en)
Other versions
KR910008183B1 (ko
Inventor
멜레발리 프랑세 (외 2)
Original Assignee
후버트 프리텔
로우셀 우크라프
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후버트 프리텔, 로우셀 우크라프 filed Critical 후버트 프리텔
Publication of KR850001163A publication Critical patent/KR850001163A/ko
Application granted granted Critical
Publication of KR910008183B1 publication Critical patent/KR910008183B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

내용 없음

Description

머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 아세틸할리드를 다음 일반식(II)의 생성물과 반응시켜 다음 일반식(I)의 생성물을 얻고 필요하다면 산의 작용으로 염화시키고, 또는 다음 일반식(III)의 아민을 다음 일반식(IV)의 산 또는 이 산의 작용 유도체와 반응시켜 상기의 일반식(I)의 생성물을 얻고 필요하다면 산의 작용으로 염화시킴을 특징으로 하는 다음 일반식(I)의 머캅토 아세트 산 및 3-머캅토아세트산 및 3-머캅토 프로피온산아미드 유도체 및 그것의 무기 또는 유기산 부가염의 제조방법.
    상기 식에서, n는 1의 수자이고, R은 4-클로로페닐기 또는 2-티아졸일기를 나타내거나 n가 2의 수자이고 R이 페닐기 또는 4-클로로페닐기를 나타낸다.
  2. 상기 1항에 있어, 아세틸 할리드를 상기 식(II)의 생성물에 반응시킴은 알칼리성 수소화물, 알칼리성 아미드, 알칼리성 알콜레이트, 알칼리성 수산화물 및 아민으로 구성된 그룹에서 선택한 염기성 약제의 존재하에 수행되는 상기의 방법.
  3. 상기 1항에 있어, 일반식(III)의 아민은 알칼리성 수소화물, 알칼리성 아미드, 알칼리성 알콜레이트, 알칼리성 수산화물 및 아민으로 구성된 그룹에서 선택한 염기성 약제의 존재하에 일반식(IV)의 산의 작용 유도체, 특히 그 산의 염화물과 반응시킴을 특징으로 하는 상기의 방법.
  4. 상기 1-3항에 있어, 일반식(II) 또는 (IV)의 생성물의 반응은 테트라히드로푸란, 염화메틸렌 및 에틸 아세테이트로 부터 선택한 용매의 존재하에 수행함을 특징으로 하는 상기의 방법.
  5. 상기 1,2 또는 4항에 있어, 염화아세틸을 테트라히드로푸란 중의 수소화나트륨의 존재하에 N-(4-클로로페닐)-2-머캅토-아세트아미드와 반응시켜 S-[2-(4-클로로 페닐아미노)-2-옥소에틸]의 에탄티오에이트를 얻게됨을 특징으로 하는 상기의 방법.
  6. 상기 1,3 또는 4항에 있어 다음 일반식(IIIa)의 아민을 필요하다면 염기의 존재하에 그리고 염화메틸렌 및 에틸아세테이트 중의 용매하에 다음 일반식(IVa)의 산의 염화물과 반응시켜 상기 일반식(I)의 상응하는 생성물을 얻고 필요하다면 산의 작용에 의해 염화시킴을 특징으로 하는 상기의 방법.
    상기 식에서 Ra는 페닐, 4-클로로페닐 또는 2-티아졸릴기를 나타내고, n는 1 또는 2의 수자로 Ra가 2-티아졸릴기를 나타내면 n=1이고 Ra가 페닐 또는 4-클로로페닐기를 나타낼 때 n=2이다.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000560A 1983-02-07 1984-02-07 머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법 KR910008183B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301863A FR2540498B1 (fr) 1983-02-07 1983-02-07 Nouveaux medicaments derives d'amides d'acide mercaptoacetique et de l'acide 3-mercaptopropionique et les compositions pharmaceutiques les renfermant
FR83-01863 1983-02-07

Publications (2)

Publication Number Publication Date
KR850001163A true KR850001163A (ko) 1985-03-16
KR910008183B1 KR910008183B1 (ko) 1991-10-10

Family

ID=9285652

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000560A KR910008183B1 (ko) 1983-02-07 1984-02-07 머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법

Country Status (16)

Country Link
US (1) US4567198A (ko)
EP (1) EP0117183B1 (ko)
JP (1) JPS59152368A (ko)
KR (1) KR910008183B1 (ko)
AT (1) ATE22555T1 (ko)
AU (1) AU569487B2 (ko)
CA (1) CA1215648A (ko)
DE (1) DE3460841D1 (ko)
DK (1) DK169254B1 (ko)
ES (1) ES528765A0 (ko)
FR (1) FR2540498B1 (ko)
GR (1) GR81411B (ko)
HU (1) HU191991B (ko)
NZ (1) NZ207057A (ko)
PT (1) PT78071B (ko)
ZA (1) ZA84571B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4611002A (en) * 1977-07-14 1986-09-09 E. R. Squibb And Sons, Inc. Carboxymethyl esters of mercaptopropanoic acids as enkephalinase inhibitors
FR2540495B1 (fr) * 1983-02-07 1986-02-14 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
US4868310A (en) * 1986-08-04 1989-09-19 Rohm And Haas Company Process for preparing isothiazolones
DE3639322A1 (de) * 1986-11-17 1988-05-26 Henkel Kgaa Verfahren zur reinigung und desinfektion von endoskopen und mittel zur durchfuehrung des verfahrens
CA2698928A1 (en) * 2007-09-28 2009-04-09 Absolute Science, Inc. Compounds and methods for treating zinc matrix metalloprotease dependent diseases
US20110190285A1 (en) * 2008-09-19 2011-08-04 Absolute Science, Inc. Methods of treating a botulinum toxin related condition in a subject
JP5546947B2 (ja) * 2010-05-13 2014-07-09 高砂香料工業株式会社 含硫カルボン酸エステル類の製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2709706A (en) * 1950-05-06 1955-05-31 Goodrich Co B F Preparation of beta-dithiocarbamyl and beta-mercapto carboxylic acid amides and the corresponding hydrazides
FR1193289A (fr) * 1958-03-14 1959-11-02 Oreal Procédé pour la mise en plis permanentée de cheveux au moyen de nouveaux composés tensio-actifs et procédé pour préparer ces composés
US3770824A (en) * 1971-05-03 1973-11-06 Monsanto Co Substituted alpha,alpha-dichloromethane-sulfenyl chlorides and their manufacture
US3878248A (en) * 1971-05-03 1975-04-15 Monsanto Co Substituted alpha, alpha-dichloro-methane-sulfenyl chlorides
AU4091178A (en) * 1977-10-25 1980-04-24 Merck & Co Inc Substituted mercapto acid amides
US4329495A (en) * 1981-05-18 1982-05-11 Pfizer Inc. Enkephalinase enzyme inhibiting compounds
FR2540495B1 (fr) * 1983-02-07 1986-02-14 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus

Also Published As

Publication number Publication date
PT78071A (fr) 1984-03-01
DK51484D0 (da) 1984-02-06
FR2540498B1 (fr) 1986-02-14
DE3460841D1 (en) 1986-11-06
PT78071B (fr) 1986-06-11
ZA84571B (en) 1985-02-27
AU2420284A (en) 1984-08-16
JPH0455188B2 (ko) 1992-09-02
EP0117183B1 (fr) 1986-10-01
CA1215648A (fr) 1986-12-23
JPS59152368A (ja) 1984-08-31
FR2540498A1 (fr) 1984-08-10
ES8500899A1 (es) 1984-11-01
AU569487B2 (en) 1988-02-04
DK51484A (da) 1984-08-08
ES528765A0 (es) 1984-11-01
DK169254B1 (da) 1994-09-26
ATE22555T1 (de) 1986-10-15
GR81411B (ko) 1984-12-11
NZ207057A (en) 1987-07-31
HU191991B (en) 1987-04-28
KR910008183B1 (ko) 1991-10-10
EP0117183A1 (fr) 1984-08-29
US4567198A (en) 1986-01-28

Similar Documents

Publication Publication Date Title
KR840001952A (ko) N-(4-(3-아미노프로필) 아미노부틸)-2-(ω)-과니디노-지방산-아미도)-2-치환된-에탄아미드 이들의 염 및 이들의 제조방법
HK185496A (en) Process for preparing florfenicaol its analogs and oxazoline intermediates thereto
KR850000406A (ko) 4-클로로-2-페닐이미다졸-5-아세트산유도체의 제조방법
KR840007011A (ko) 세펨 화합물의 제조방법
KR920008018A (ko) 피페라진 유도체의 제조방법
KR850001163A (ko) 머캅토-아세트산 및 머캅토프로피온산 아미드 유도체의 제조방법
KR860000243A (ko) 아민유도체의 제조방법
KR910006239A (ko) 4급화된 이미다졸린 직물 컨디쇼닝 화합물을 제조하는 방법
KR830009065A (ko) 아미도-아미노산의 제조방법
KR880003965A (ko) 이노소오스 유도체, 그의 제조방법 및 용도
KR840002358A (ko) 알파 2-길항작용을 일으키는 약제조성물 및 그 방법
ES485650A1 (es) Procedimiento para la preparacion de 1,2,3-tiadiazol-5-il- ureas
KR870007106A (ko) 테트라클로로-2-시아노벤조산의 알킬에스테르의 제조방법
KR850004495A (ko) 치환된 o-아실글리코아미드류의 제조방법
KR840007869A (ko) N-아미노피리디늄 베타인의 신규 유도체 및 그 제조방법과 이를 함유한 약제학적 조성물
KR830008971A (ko) 페닐알카노산의 제조방법
EP0504404A4 (en) Process for producing 3-substituted thio-3-cephem compound
KR850005830A (ko) 2-알콕시아미노설포닐벤젠-설포닐우레아의 제조방법
KR840004420A (ko) N-(1,3-디티올린-2-알리덴)아닐린 유도체의 제조방법
KR970001318A (ko) 산할로겐화물 또는 술폰산할로겐화물의 제조방법
KR920019742A (ko) L-프롤린 유도체의 제조방법
KR890002011A (ko) 5-할로 게노-6-아미노-니코틴산 할라이드. 이의 제조방법 및 용도
KR840006209A (ko) 1,2,3,4-테트라하이드로-1-아미노메틸-4-페닐이소퀴놀린의 제조방법
KR850007800A (ko) 세팔로스포린 유도체의 에스테르 제조방법
KR850005406A (ko) 치환된 살리실산 아미드의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19961001

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee